Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
As the COVID-19 pandemic lingers on, clinical trials for patients with cancer have never been more important. Oncology is a highly evidence-based discipline, with much still to do, constantly striving to improve outcomes for our patients. The challenges COVID has wrought on already stretched health systems reduced enrolment of cancer patients into trials by over 60% [ ].
SARS-CoV-2 (COVID-19) requires little introduction. COVID-19 has already had, and will progressively have, profound consequences on our practice during the pandemic and beyond. As oncologists, we pride ourselves that our practice is evidence-based. However, we are increasingly making decisions with limited or an absence of high-quality evidence.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
